Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) were found more recently in a group of patients with demyelinating disease whose clinical features partially overlap with NMOSD and a new disease entity associated with MOG-IgG, called MOG antibody-associated disease (MOGAD), was suggested (2). The gene discussed is MOG; the disease is demyelinating disease.